Austin, Texas (PRWEB) October 31, 2013
The law firm of Hissey Kientz, LLP reports that two conferences will be held next month for the consolidated state and federal Mirena IUD litigations underway, according to court documents. The first conference will be held on November 20th in New Jersey’s Bergen County Superior Court. (In Re: Mirena Litigation; Case No. 297) The second Mirena conference is to take place on November 21 in U.S. District Court, Southern District of New York. (In re: Mirena IUD Products Liability Litigation, MDL No. 2434)
In 2009, the U.S. Food and Drug Administration (FDA) issued two warning letters to Bayer Pharmaceuticals stating that the manufacturer “presents unsubstantiated claims, minimizes the risks of using Mirena, and includes false or misleading presentations regarding Mirena.” The FDA warning letters were issued in response to Mirena online advertisements and videos.*
According to a June 18 Kansas City NBC news report, the FDA has logged more than 70,000 complaints about the Mirena IUD since 2000. Mirena complaints include reports of serious complications such as ectopic pregnancy, uterine perforation, device migration pelvic inflammatory disease, abnormal vaginal bleeding and IUD expulsion.**
Patients who experienced uterine perforation, IUD migration, ectopic pregnancy or other serious side effects after being implanted with a Mirena IUD may wish to speak with a lawyer to find out if they are eligible to file a lawsuit. For more information about whether you may have a case, contact the attorneys at Hissey Kientz, LLP by calling toll-free at 1-866-275-4454 or by email at info(at)hkllp(dot)com.
About Hissey Kientz, LLP
Hissey Kientz, LLP represents individuals experiencing complications from the Mirena IUD, as well as victims of mesothelioma and other asbestos-related diseases, birth defects linked to the antidepressant drugs Zoloft, Lexapro, Celexa, Paxil and Effexor, problems with transvaginal mesh, Stryker and BioMet hip replacements, GranuFlo dialysis acid concentrate and other defective drugs and medical devices.